The slightly increased uptake in both experimental groups in lymphoid organs (e.g., thymus, lymph nodes), which may have been also affected by the BLM treatment (64), is most likely caused by the presence of activated macrophages expressing FR–β (65, 66), a phenomenon, previously observed in lymph nodes of tumor-bearing mice (61). This evidence concerns the gene FOLR2 and neoplasm.